Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia.
作者信息
Chen Xiaolin, Cai Yili, Ge Xin
机构信息
Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, China.
出版信息
Arch Med Sci. 2020 Aug 10;16(5):1254-1256. doi: 10.5114/aoms.2020.97971. eCollection 2020.
Abstract
摘要
相似文献
1
Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia.无症状高尿酸血症患者发生别嘌醇诱发的超敏反应综合征，随后出现无痛性甲状腺炎。
Arch Med Sci. 2020 Aug 10;16(5):1254-1256. doi: 10.5114/aoms.2020.97971. eCollection 2020.
2
Fatal allopurinol-induced hypersensitivity syndrome associated with pancreatic abnormalities.致命性别嘌醇诱导的超敏反应综合征伴胰腺异常。
J Clin Rheumatol. 2010 Jun;16(4):170-1. doi: 10.1097/RHU.0b013e3181dfbaf7.
3
Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.别嘌醇的使用与致命性过敏反应风险：来自台湾的全国性基于人群的研究。
JAMA Intern Med. 2015 Sep;175(9):1550-7. doi: 10.1001/jamainternmed.2015.3536.
4
[Allopurinol hypersensitivity syndrome. A report of two cases].[别嘌醇超敏综合征。两例报告]
Rev Med Inst Mex Seguro Soc. 2016 Mar-Apr;54(2):261-4.
5
[Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia].
Dtsch Med Wochenschr. 2014 Dec;139(49):2537-40. doi: 10.1055/s-0034-1387408. Epub 2014 Nov 25.
6
[Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome].[无症状性高尿酸血症患者使用别嘌醇治疗期间发生的超敏反应综合征并导致死亡]
Dtsch Med Wochenschr. 2001 Nov 23;126(47):1331-4. doi: 10.1055/s-2001-18563.
7
Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.无症状性高尿酸血症治疗后发生致命性别嘌呤醇超敏综合征。
BMJ. 2005 Sep 17;331(7517):623-4. doi: 10.1136/bmj.331.7517.623.
8
[Allopurinol-induced hypersensitivity syndrome].
Orv Hetil. 2012 Apr 15;153(15):586-91. doi: 10.1556/OH.2012.29324.
9
The allopurinol hypersensitivity syndrome.
J Am Acad Dermatol. 1979 Oct;1(4):365-74. doi: 10.1016/s0190-9622(79)70031-4.
10
Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment.别嘌醇诱发的复发性药物超敏反应综合征：病理生理学与治疗
Ren Fail. 2008;30(3):327-9. doi: 10.1080/08860220701861045.
本文引用的文献
1
An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.药物过敏反应的分子机制最新研究综述
J Immunol Res. 2018 Feb 13;2018:6431694. doi: 10.1155/2018/6431694. eCollection 2018.
2
Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.尼伏鲁单抗致甲状腺炎的临床特征：病例系列研究。
Thyroid. 2017 Jul;27(7):894-901. doi: 10.1089/thy.2016.0562. Epub 2017 Jun 21.
3
Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.泰国人群中别嘌醇诱发严重皮肤不良反应的危险因素。
Pharmacogenet Genomics. 2017 Jul;27(7):255-263. doi: 10.1097/FPC.0000000000000285.
4
HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.别嘌醇所致皮肤不良反应的HLA - B (*) 58:01：对泰国临床解读的意义
Front Pharmacol. 2016 Jul 18;7:186. doi: 10.3389/fphar.2016.00186. eCollection 2016.
5
Genotyping HLA-B*5801 for Allopurinol-Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method.通过基因分型HLA - B*5801预测别嘌醇诱导的严重皮肤不良反应：一种准确且快速的方法。
Clin Transl Sci. 2015 Dec;8(6):834-6. doi: 10.1111/cts.12365. Epub 2015 Dec 14.
6
HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.HLA - B*58:01与汉族患者中别嘌醇诱导的严重皮肤不良反应密切相关：一项多中心回顾性病例对照临床研究。
Br J Dermatol. 2015 Aug;173(2):555-8. doi: 10.1111/bjd.13688. Epub 2015 Jun 22.
7
Involvement of Human Herpesvirus 6 Infection in Renal Dysfunction Associated with DIHS/DRESS.人疱疹病毒6型感染与药物超敏反应伴嗜酸性粒细胞增多和系统症状（DIHS/DRESS）相关的肾功能障碍
Acta Derm Venereol. 2016 Jan;96(1):114-5. doi: 10.2340/00015555-2149.
8
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).145例药物性超敏反应综合征/伴嗜酸性粒细胞增多和全身症状的药物反应患者的后遗症：由亚洲严重皮肤不良反应研究委员会（ASCAR）开展的调查
J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27.
9
HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.HLA-B58 有助于临床决策是否在慢性肾功能不全患者中开始使用别嘌醇。
Nephrol Dial Transplant. 2011 Nov;26(11):3567-72. doi: 10.1093/ndt/gfr060. Epub 2011 Mar 10.
10
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.韩国人群中 HLA Ⅰ类等位基因与别嘌醇诱导的 SCAR 的阳性和阴性关联。
Pharmacogenet Genomics. 2011 May;21(5):303-7. doi: 10.1097/FPC.0b013e32834282b8.
Zotero 插件